Looking for pharma deals? Explore marketplace now Explore
FDA approved a once-daily Zilbrysq autoinjector for generalized myasthenia gravis. It launches in early 2027 with the same meningococcal infection warning.
This is a short summary. The full story is published by Inkl.
Read full story at Inkl
FDA gave Jemperli accelerated approval for dMMR rectal cancer. Most trial patients skipped surgery, but the data are interim. What patients should…
The FDA approved Ryzumvi eye drops for presbyopia in adults. See how the nightly drop works, trial results, side effects, and what remains unknown.
Awiqli® offers children 10 years and older a once-weekly basal insulin alternative, reducing basal injection frequency from seven times per week to…
Awiqli® offers children 10 years and older a once-weekly basal insulin alternative, reducing basal injection frequency from seven times per week to…
Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.
Exclusive introductory offer for new advertisers
Get offers from suppliers
Your product details and requirements may be published on the marketplace.
Fields marked with * are mandatory.